Pfizer hair loss drug Litfulo approved in UK
Alopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps.
Advertisement
Bengaluru: Britain's medicines regulator has approved Pfizer Inc's drug to treat hair loss caused by an autoimmune disease.
The drug, branded as Litfulo, has been approved by UK's Medicines and Healthcare products Regulatory Agency (MHRA) for people aged 12 years and older suffering from severe alopecia areata.
It has already been approved for use in Europe and the United States.
Alopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps
Read also: Hair loss drug: Pfizer Litfulo for adults, adolescents approved by USFDA
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.